GlassScriptPhysician profile
Scott R Littrell
NPI 1255643722
$3,892.15
in general payments reported to CMS, 2019-2025
40 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $210 · 2021: $611 · 2022: $690 · 2023: $506 · 2024: $465 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,146.69 | 2019-2025 | Grafix Pl, Stravix Pl, Renasys Go V2 Home |
| Paratek Pharmaceuticals, INC. | $455.34 | 2019-2025 | Nuzyra |
| Horizon Therapeutics Plc | $237.72 | 2019-2023 | Krystexxa |
| Bioventus LLC | $212.63 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $204.66 | 2022-2024 | Senza |
| Stryker Corporation | $172.44 | 2019-2024 | Prostep Mica, Spy-Phi System, Actishield |
| Paragon 28, INC. | $166.83 | 2019-2024 | Smart Lapidus, Bun-Yo-Matic, Phantom Intramedullary Nail |
| Melinta Therapeutics, LLC | $127.59 | 2019 | |
| Ge Healthcare | $79.47 | 2025 | |
| Amgen INC. | $75.92 | 2025 | Krystexxa |
| Inari Medical, INC. | $73.73 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ets Wound Care LLC | $62.47 | 2025 | Mirragen Advanced Wound Matrix |
| Tenex Health INC. | $60.60 | 2019 | |
| Globus Medical, INC. | $59.47 | 2025 | Vyrsa V1, Ossifuse |
| Zimmer Biomet Holdings, INC. | $56.64 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $52.16 | 2023-2024 | |
| Kerecis Limited | $49.91 | 2022 | |
| Alfasigma USA, INC. | $43.49 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $37.46 | 2025 | |
| Organogenesis INC. | $37.07 | 2021-2022 | |
| Kci USA, INC. | $36.53 | 2020-2022 | |
| Celularity INC. | $36.00 | 2019 | |
| Reprise Biomedical, INC. | $32.78 | 2024 | Miro3d |
| Depuy Synthes Sales INC. | $32.54 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $32.04 | 2022 | |
| Misonix INC | $29.74 | 2019 | |
| Access Pro Medical, LLC | $28.35 | 2023 | Matriderm |
| Trimed, INC. | $26.95 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.69 | 2024 | Austedo Xr |
| Biocomposites INC | $25.20 | 2024 | |
| Medtronic, INC. | $22.41 | 2025 | Inceptiv |
| Abbott Laboratories | $21.33 | 2023 | Proclaim |
| Next Science LLC | $21.20 | 2025 | Blastx, Xperience |
| Triad Life Sciences INC. | $18.20 | 2022 | |
| Integra Lifesciences Corporation | $16.92 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novo Nordisk INC | $16.35 | 2025 | Wegovy |
| Lilly USA, LLC | $16.23 | 2024 | |
| Orthofix Medical, INC. | $15.06 | 2019 | |
| Solventum Corporation | $13.70 | 2024 | Activ.A.C. |
| Axsome Therapeutics, INC. | $12.64 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Littrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.